Davis Polk advised InSilico Medicine in the transaction.InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million. The…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
